Latest Breaking News On - Elevated lipoprotein - Page 1 : comparemela.com

AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023

/PRNewswire/ Amgen (NASDAQ:AMGN) today announced data from the final analysis of the Phase 2 OCEAN(a)-DOSE study of olpasiran, a small interfering RNA.

Puerto ricoUnited statesNoord hollandArterioscler thromb vascClin lipidolJessica akopyanJohns hopkinsColl cardiolC michael gibsonPrnewswire amgenMichellel odonoghueJustin claeysPaul burtonTeneobio incBeigene ltdExchange commission

AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023

AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Puerto ricoUnited statesNoord hollandArterioscler thromb vascJustin claeysJohns hopkinsPaul burtonPrnewswire amgenJessica akopyanC michael gibsonColl cardiolMichellel odonoghueClin lipidolTeneobio incBeigene ltdExtension program on long

Family Heart Foundation Study Shows Increased Rate of Cardiovascular Events Among Individuals With High Lipoprotein(a)

Family Heart Foundation Study Shows Increased Rate of Cardiovascular Events Among Individuals With High Lipoprotein(a)
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Juliet babrosMaryp mcgowanFamily heart foundationFh foundationEuropean atherosclerosis society congressPoster presentationEuropean atherosclerosis societyObservational studyCardiovascular eventsElevated lipoproteinFamily heart